학술논문

Three-Year Overall Survival of Patients with Advanced Non-Small-Cell Lung Cancers with ≥50% PD-L1 Expression Treated with First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)

Document Type

Article

Author

Decroisette, C.; Pérol, M.; Greillier, L.; Curcio, H.; Ricordel, C.; Auliac, J.-B.; Chouaïd, C.; Falchero, L.; Veillon, R.; Vieillot, S.; Guisier, F.; Marcq, M.; Justeau, G.; Bigay-Game, L.; Bernardi, M.; Doubre, H.; Pinsolle, J.; Amrane, K.; Descourt, R.

Source

In: Journal of Immunotherapy. (Journal of Immunotherapy, 1 January 2024, 47(1):16-20)

Subject

Language

English

ISSN

15374513
15249557

Online Access

Full Text (LWW Journals - Ovid) Full Text (LWW total - Ovid) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송